Dr. Israel Steiner is a specialized Neurologist in Israel. And one of the most sought after medical specialists in Petah Tikva, Israel. The doctor has over 30 Years of experience and is associated with Rabin Medical Center.
Association and Memberships Dr. Israel Steiner is part of:
- Israel Medicine Association
Qualifications :
- Medical School - Hebrew University, Jerusalem
- Fellowship molecular virology Wistar Institute, Philadelphia
Hospital Address :
Rabin Medical Center, Ze'ev Jabotinsky Street, Petah Tikva, Israel
What is the medical expertise of Dr Israel Steiner?
- Dr Israel Steiner is a renowned neurologist specializing in neuroinfectious diseases such as meningitis and viral encephalitis, and conditions like stroke, Parkinson's, dementia and Epilepsy.
- He has more than 30 years of experience as an esteemed neurologist. He is affiliated with organizations such as the American Academy of Neurology, the European Neurological Society, and the American Neurological Association. He is also a founding member of the International Society for Neurovirology.
- Dr Steiner served as the Chairman of the Scientific Committee of the Israel Neurological Association and the Scientific Council of the Israel Medical Association.
- He is also a scientific board member of 3 biopharmaceutical companies and serves on the Editorial Board of 4 scientific journals.
- Over the course of his career, Dr Steiner has published many peer-reviewed papers in reputed journals. These include:
- Taba P, Schmutzhard E, Forsberg P, Lutsar I, Ljøstad U, Mygland Ã
, Levchenko I, Strle F, Steiner I. EAN consensus review on prevention, diagnosis and management of tick-borne encephalitis. Eur J Neurol. 2017 Oct;24(10):1214-e61.
- Lotan I, Hellman MA, Steiner I. Diagnostic criteria of chronic inflammatory demyelinating polyneuropathy in diabetes mellitus. Acta Neurol Scand. 2015 Oct;132(4):278-83.
- Hellmann MA, Lev N, Lotan I, Mosberg-Galili R, Inbar E, Luckman J, Fichman-Horn S, Yakimov M, Steiner I. Tumefactive demyelination and a malignant course in an MS patient during and following fingolimod therapy. J Neurol Sci. 2014 Sep 15;344(1-2):193-7.